Precision BioSciences, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$34M
↑+5261.1% +$34Mvs FY2024 (Q4)
Gross Profit
$34M
↑+5261.1% +$34Mvs FY2024 (Q4)
Operating Income
$13M
Net Income
$12M
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $34M | $638K |
| COGS | $0 | $0 |
| Gross Profit | $34M | $638K |
| R&D | $14M | $16M |
| SG&A | $0 | $0 |
| D&A | $345K | $454K |
| Other OpEx | $7M | $0 |
| Operating Income | $13M | $0 |
| Interest Exp. | $348K | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $12M | $0 |
| Tax | $0 | $0 |
| Net Income | $12M | $0 |
QuarterCharts · SEC EDGAR data · DTIL · Comparing FY2025 (Q4) vs FY2024 (Q4)